Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers
Status:
Completed
Trial end date:
2020-05-18
Target enrollment:
Participant gender:
Summary
A randomized, open label, single dose, 2-sequence, 4-period, cross-over phase I clinical
trial to compare and evaluate the safety and pharmacokinetics after oral administration of
"LodienT tablet 80/2.5mg(telmisartan/s-amlodipine)" and "TWINSTA tablet
80/5mg(telmisartan/amlodipine)" in healthy adult volunteers.